Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5Y08
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,122
Award facts
- Contract value 100% obligated
- $16,121.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,121.66 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive procurement. The award was executed on January 15, 2026, with an ultimate completion date of January 16, 2026, and performance will occur at the vendor's location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a $1 billion vehicle through December 2026 that serves as the primary acquisition mechanism for pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company holds a significant market position in supplying a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains through competitively awarded contracts. This particular delivery order for Ozempic, a diabetes medication, exemplifies the company's role in fulfilling critical pharmaceutical requirements for the Defense Health Agency and other federal healthcare programs through its established supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F5Y08?
SPE2DR26F5Y08 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F5Y08 worth?
The government has obligated $16,122 on SPE2DR26F5Y08.
Is contract SPE2DR26F5Y08 an order under another contract?
Yes. SPE2DR26F5Y08 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Y08 competed?
The extent of competition for SPE2DR26F5Y08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award